Abstract
Inhibitors of cholesterol absorption have been sought for decades as a means to treat and prevent cardiovascular diseases associated with hypercholesterolemia. Ezetimibe is the one clear success story in this regard, and other compounds with similar efficacy continue to be sought. In the last decade, the laboratory mouse, with all its genetic power, has become the premier experimental model for discovering the mechanisms underlying cholesterol absorption and has become a critical tool for preclinical testing of potential pharmaceutical entities. This chapter briefly reviews the history of cholesterol absorption research and the various gene candidates that have come under consideration as drug targets. The most common and versatile method of measuring cholesterol absorption is described in detail along with important considerations when interpreting results, and an alternative method is also presented. In recent years, reverse cholesterol transport has become an area of intense new interest for drug discovery since this process is now considered another key to reducing cardiovascular disease risk. The ultimate measure of reverse cholesterol transport is sterol excretion and a detailed description is given for measuring neutral and acidic fecal sterols and interpreting the results.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Hui, D. Y. and Howles, P. N. (2005) Molecular mechanisms of cholesterol absorption and transport in the intestine. Semin. Cell Dev. Biol. 16, 183–192.
Levy, E., Spahis, S., Sinnett, D., Peretti, N., Maupas-Schwalm, F., et al. (2007) Intestinal cholesterol transport proteins: an update and beyond. Curr. Opin. Lipidol. 18, 310–318.
Hui, D. Y., Labonté, E. D., and Howles, P. N. (2008) Development and physiological regulation of intestinal lipid absorption III. Intestinal transporters and cholesterol absorption. Am. J. Physiol. Gastrointest. Liver Physiol. 294, 839–843.
Westergaard, H. and Dietschy, J. M. (1976) The mechanism whereby bile acid micelles increase the rate of fatty acid and cholesterol uptake into the intestinal mucosal cells. J. Clin. Invest. 58, 97–108.
Thurnhofer, H. and Hauser, H. (1990) Uptake of cholesterol by small intestinal brush border membrane is protein-mediated. Biochemistry 29, 2142–2148.
Borja, C. R., Vahouny, G. V., and Treadwell, C. R. (1964) Role of bile and pancreatic juice in cholesterol absorption and esterification. Am. J. Physiol. 206, 223–228.
Gallo, L. L., Clark, S. B., Myers, S., and Vahouny, G. V. (1984) Cholesterol absorption in rat intestine: Role of cholesterol esterase and acyl coenzyme A:cholesterol acyl transferase. J. Lipid Res. 25, 604–612.
Fernandez, E. and Borgström, B. (1989) Effects of tetrahydrolipstatin, a lipase inhibitor, on absorption of fat from the intestine of the rat. Biochim. Biophys. Acta 1001, 249–255.
McKean M. L., Commons, T .J., Berens, M. S., Hsu, P. L., Ackerman, D. M., et al. (1992) Effect of inhibitors of pancreatic cholesterol ester hydrolase (PCEH) on 14C-cholesterol absorption in animal models. FASEB J. 6, A1388.
Krause, B. R., Sliskovic, D. R., Anderson, M., and Homan, R. (1998) Lipid-lowering effects of WAY-121,898, an inhibitor of pancreatic cholesteryl ester hydrolase. Lipids 33, 489–498.
Howles, P. N., Carter, C. P., and Hui, D. Y. (1996) Dietary free and esterified cholesterol absorption in cholesterol esterase (bile salt-stimulated lipase) gene-targeted mice. J. Biol. Chem. 271, 7196–7202.
Weng, W., Li, L., van Bennekum, A. M., Potter, S. H., Harrison, E. H., et al. (1999) Intestinal absorption of dietary cholesteryl ester is decreased but retinyl ester absorption is normal in carboxyl ester lipase knockout mice. Biochemistry 38, 4143–4149.
Camarota, L. M., Chapman, J. M., Hui, D. Y., and Howles, P. N. (2004) Carboxyl ester lipase cofractionates with scavenger receptor BI in hepatocyte lipid rafts and enhances selective uptake and hydrolysis of cholesteryl esters from HDL3. J. Biol. Chem. 279, 27599–27606.
Chaikoff, I. L., Bloom, B., Siperstein, M. D., Kiyasu, J. Y., Reinhardt, W. O., et al. (1952) C14-cholesterol I: Lymphatic transport of absorbed cholesterol-4-C14. J. Biol. Chem. 194, 407–412.
Heider, J. G., Pickens, C. E., and Kelly, L. A. (1983) Role of acyl CoA:cholesterol acyltransferase in cholesterol absorption and its inhibition by 57-118 in the rabbit. J. Lipid Res. 24, 1127–1134.
Clark, S. B. and Tercyak, A. M. (1984) Reduced cholesterol transmucosal transport in rats with inhibited mucosal acyl CoA:cholesterol acyltransferase and normal pancreatic function. J. Lipid Res. 25, 148–159.
Gallo, L. L., Wadsworth, J. A., and Vahouny, G. V. (1987) Normal cholesterol absorption in rats deficient in intestinal acyl coenzyme A:cholesterol acyltransferase activity. J. Lipid Res. 28, 381–387.
Buhman, K. K., Accad, M., Novak, S., Choi, R. S., Wong, J. S., et al. (2000) resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice. Nat. Med. 6, 1341–1347.
Yagu, H., Kitamine, T., Osuga, J., Tozawa, R., Chen, Z., et al. (2000) Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia. J. Biol. Chem. 275, 21324–21330.
Leon, C., Hill, J. S., and Wasan, K. M. (2005) Potential role of acyl-coenzyme A:cholesterol transferase (ACAT) inhibitors as hypolipidemic and antiatherosclerosis drugs. Pharm. Res. 22, 1578–1588.
Rudel, L. L., Lee, R. G., and Parini, P. (2005) ACAT2 is a target for treatment of coronary heart disease associated with hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 25, 1112–1118.
Lada, A. T., Davis, M., Kent, C., Chapman, J., Tomoda, H., et al. (2004) Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay: individual ACAT uniqueness. J. Lipid Res. 45, 378–386.
VanHeek, M., France, C. F., Compton, D. S., McLeon, R. L., Yumibe, N. P., et al. (1997) In vivo metabolism-based discovery of a potent absorption cholesterol inhibitor, SCH58235, in the rat, and rhesus monkey through the identification of the active metabolites of SCH48461. J. Pharmacol. Exp. Therap. 283, 157–163.
Altmann S. W., Davis, H. R., Zhu, L., Yao, X., Hoos, L. M., et al. (2004) Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption. Science 303, 1201–1204.
Garcia-Calvo, M., Lisnock, H. G., Bull, B. E., Hawes, D. A., Burnett, M. P., et al. (2005) The target of ezetimibe is Niemann-Pick C1-like 1 (NPC1L1). Proc. Natl. Acad. Sci. U.S.A. 102, 8132–8137.
Ziajka, P. E., Reis, M., Kreul, S., and King., H. (2004) Initial low-density lipoprotein response to statin therapy predicts subsequent low-density lipoprotein response to the addition of ezetimibe. Am. J. Cardiol. 93, 779–780.
Richmond, B. L., Boileau, A. C., Zheng, S., Huggins, K. W., Gramholm, N. A., et al. (2001) Compensatory phospholipid digestion is required for cholesterol absorption in pancreatic phospholipase A(2)-deficient mice. Gastroenterology 120, 1193–1202.
Huggins, K. W., Boileau, A. C., and Hui, D. Y. (2002) Protection against diet-induced obesity and insulin resistance in group 1B PLA2 deficient mice. Am. J. Physiol. Endocrinol. Metab. 283, E994-E1001.
Homan, R. and Hamelehle, K. L. (1998) Phospholipase A2 relieves phosphatidylcholine inhibition of micellar cholesterol absorption and transport by human intestinal cell line Caco-2. J. Lipid Res. 39, 1197–1209.
Huggins, K. W., Camarota, L. M., Howles, P. N., and Hui, D. Y. (2003) Pancreatic triglyceride lipase deficiency minimally affects dietary fat absorption but dramatically decreases dietary cholesterol absorption in mice. J. Biol. Chem. 278, 42899–42905.
Mittendorf, B., Ostlund, R. E., Patterson, B. W., and Klein, S. (2001) Orlistat inhibits dietary cholesterol absorption. Obes. Res. 9, 599–604.
Drew, B. S., Dixon, A. F., and Drew, J. B. (2007) Obesity management: update on orlistat. Vasc. Health Risk Manag. 3, 817–821.
Quintão, E., Grundy, S. M., and Ahrens, E. H. (1971) An evaluation of four methods for measuring cholesterol absorption by the intestine in man. J. Lipid Res. 12, 221–232.
Sanders, D. J., Minter, H. J., Howes, D., and Hepburn, P. A. (2000) The safety evaluation of phytosterol esters. Part 6. The comparative absorption and tissue distribution of phytosterols in the rat. Food Chem. Toxicol. 38, 485–491.
Igel, M., Giesa, U., Lutjohann, D., and von Bergmann, K. (2003) Comparison of the intestinal uptake of cholesterol, plant sterols, and stanols in mice. J. Lipid Res. 44, 533–538.
Kastelein, J. J., van Leuven, S. I., Burgess, L., Evans, G. W., Kuivenhoven, J. A., Barter, P. J., Revkin, J. H., Grobbee, D. E., Riley, W.A., Shear, C. L., Duggan, W. T., Bots, M. L. and RADIANCE 1 investigators. (2007) Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N. Engl. J. Med. 356, 1620–1630.
Forrester, J. S., Makkar, R., Shah, P. K. (2005) Increasing high-density lipoprotein cholesterol in dyslipidemia by cholesteryl ester transfer protein inhibition. Circulation 111, 1847–1854.
Tchoua, U., D'Souza, W., Mukhamedova, N., Blum, D., Niesor, E., Mizrahi, J., Maugeais, C., Sviridov, D. (2008 The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport. Cardiovasc. Res. 77, 732–739.
Post, S. M., de Crom, R., van Haperen, R., van Tol, A., and Princen, H. M. (2003) Increased fecal bile acid excretion in transgenic mice with elevated expression of human phospho lipid transfer protein. Arterioscler. Thromb. Vasc. Biol. 23, 892–897.
Zhang, Y. Z., Zanotti, I., Reilly, M. P., Glick, J. M., Rothblat, G. H., et al. (2003) Overexpression of apolipoprotein A-I promotes reverse cholesterol transport from macrophages to feces in vivo. Circulation 108, 661–663.
Carter C. P., Howles, P. N., and Hui, D. Y. (1997) Genetic variation in cholesterol absorption efficiency among inbred strains of mice. J Nutr. 127, 1344–1348.
Zilversmit, D. B. and Hughes, L. B. (1974) Validation of a dual-isotope plasma ratio for measurement of cholesterol absorption in rats. J. Lipid Res. 15, 465–473.
Millar, J. S., Cromley, D. A., McCoy, M. G., Rader, D. J., and Billheimer, J. T. (2005) Determining hepatic triglyceride production in mice: comparison of poloxamer 407 with Triton WR-1339. J. Lipid Res. 46, 2023–2028.
Jandacek, R. J., Heubi, J. E., and Tso, P. (2004) A novel, noninvasive method for the measurement of intestinal fat absorption. Gastroenterology 127, 139–144.
LaBonté, E. D., Camarota, L. M., Rojas, J. C., Jandacek R. J., Gilham, D.E., et al. (2008) Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1 -/- mice. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G776-G783.
Osono, Y., Woollett, L. A., Herz, J., and Dietschy, J. M. (1995) Role of the low density lipoprotein receptor in the flux of cholesterol across the tissues of the mouse. J. Clin. Invest. 95, 1124–1132.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Howles, P.N. (2010). Cholesterol Absorption and Metabolism. In: Proetzel, G., Wiles, M. (eds) Mouse Models for Drug Discovery. Methods in Molecular Biology, vol 602. Humana Press. https://doi.org/10.1007/978-1-60761-058-8_10
Download citation
DOI: https://doi.org/10.1007/978-1-60761-058-8_10
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-057-1
Online ISBN: 978-1-60761-058-8
eBook Packages: Springer Protocols